Virtual Reality Motion Desensitization Platform Market Report 2025

The virtual reality motion desensitization platform market size has grown exponentially in recent years. It will grow from $1.64 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth during the historic period is linked to increasing adoption of virtual reality in healthcare, rising demand for non-pharmacological therapy solutions, growing awareness of motion sickness disorders, higher investment in immersive therapy, and a greater need for personalized rehabilitation programs.

The virtual reality motion desensitization platform market size is expected to see exponential growth in the next few years. It will grow to $4.52 billion in 2029 at a compound annual growth rate (CAGR) of 22.4%. The growth projected for the forecast period is driven by growing adoption of VR-based therapeutic solutions, increasing demand for remote and home-based therapy, rising investment in VR healthcare startups, and expanding awareness of mental health and motion-related disorders. Primary trends during the forecast period include advancements in immersive VR experiences, integration of artificial intelligence for personalized therapy, innovations in wearable and haptic devices, increasing adoption of cloud-based VR platforms, and incorporation of real-time patient monitoring systems.

The rising prevalence of mental health disorders is expected to support the growth of the virtual reality motion desensitization platform market. Mental health disorders are conditions that impact a person’s emotions, thoughts, behaviors, and overall psychological well-being. The increase in mental health disorders is linked to rising stress caused by modern lifestyles, including work-related pressure, social isolation, and continuous digital engagement. Virtual reality motion desensitization platforms assist in treating mental health disorders by offering immersive and controlled environments, making them suitable for therapy targeting anxiety, phobias, and post-traumatic stress disorder. These platforms help lower psychological distress through gradual exposure and adaptive therapy, which enhances patient outcomes and participation. For example, in May 2024, the American Psychiatric Association reported that 43 percent of adults in the United States felt more anxious than the previous year, an increase from 37 percent in 2023 and 32 percent in 2022. This growing prevalence is driving demand for virtual reality motion desensitization platforms.

Key companies in the virtual reality motion desensitization platform market are focusing on advanced innovations such as artificial intelligence-powered personalized therapy systems to improve treatment results, increase patient engagement, and reduce therapy barriers and adaptation periods. These systems use artificial intelligence to create customized therapeutic environments and scenarios tailored to individual needs, enhancing desensitization and rehabilitation outcomes. For instance, in September 2024, Interacoustics A/S, a medical equipment manufacturer based in Denmark, introduced the Virtualis balance rehabilitation solutions. This system combines immersive virtual reality with dynamic posturography force plates to simulate real-world settings and support rehabilitation strategies such as adaptation, substitution, and habituation. The system features adaptive modules powered by artificial intelligence, including SkiVR and MotionVR, which automatically adjust therapy intensity based on patient performance. These tools offer precise and engaging balance rehabilitation without requiring constant supervision and provide effective motion desensitization for vestibular disorders through progressive virtual reality exposure.

In April 2023, XRHealth Ltd., an extended reality therapeutics company based in the United States, merged with Amelia Virtual Care for an undisclosed amount. Through this merger, XRHealth aims to integrate Amelia’s clinician-centered virtual reality software with its virtual treatment room operations to create a comprehensive extended reality therapeutics platform. This platform is designed to address physical rehabilitation, behavioral health, and chronic pain across various care environments. Amelia Virtual Care is a health technology company based in Spain that specializes in virtual reality motion desensitization platforms.

Major players in the virtual reality motion desensitization platform market are MindMaze SA, XRHealth Ltd., Bertec Corporation, NeuroSync Inc., Virtual Reality Medical Center Inc., PsyTech VR Inc., C2Care, Virtually Better Inc., Cyclops Medtech Pvt. Ltd., Kinequantum, Neuroequilibrium, Saebo Inc., Kinesix VR, Rey, Rewin Health, and PhysioSensing Vertigo.

North America was the largest region in the virtual reality motion desensitization platform market in 2024. The regions covered in virtual reality motion desensitization platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the virtual reality motion desensitization platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

A virtual reality (VR) motion desensitization platform is an immersive system designed to help individuals gradually adapt to motion-related stimuli that cause discomfort, dizziness, or motion sickness. It exposes users to controlled virtual environments simulating movement, enabling progressive desensitization. This platform helps reduce sensitivity to motion, improve balance, and enhance comfort during real-world movement experiences.

The primary components of a VR motion desensitization platform include hardware, software, and services. Hardware consists of VR headsets, motion sensors, haptic devices, and controllers used to deliver immersive therapy for motion adaptation and sensitivity reduction. Deployment can occur through on-premises or cloud-based modes. Applications span healthcare and therapy, gaming and entertainment, education and training, military and defense, and other areas. Key end users include hospitals and clinics, rehabilitation centers, academic and research institutes, military organizations, and other organizations.

The virtual reality motion desensitization platform market research report is one of a series of new reports that provides virtual reality motion desensitization platform market statistics, including the virtual reality motion desensitization platform industry global market size, regional shares, competitors with the virtual reality motion desensitization platform market share, detailed virtual reality motion desensitization platform market segments, market trends, and opportunities, and any further data you may need to thrive in the virtual reality motion desensitization platform industry. This virtual reality motion desensitization platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The virtual reality motion desensitization platform market consists of revenues earned by entities by providing services such as personalized virtual reality (VR) therapy sessions, motion sensitivity assessments, rehabilitation programs, training for balance and vestibular disorders, and monitoring of patient progress through immersive virtual reality (VR) experiences. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual reality motion desensitization platform market also includes sales of peripheral devices for enhanced immersion, virtual reality (VR) headsets, motion-tracking sensors, specialized desensitization software, and biometric and neurofeedback devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.